Ifosfamide
Testicular Cancer
Fudan UniversityPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 81/ 100
Competitive context
10 Active assets in the Testicular Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TESTOSTERONE UNDECYLATE University Medical Center Groningen | Phase 2/3 | BB |
CIS-DIAMMINEDICHLOROPLATINUM II Fudan University | Phase 2 | B |
Etarfolatide Endocyte | Phase 2 | B |
Durvalumab Ludwig Institute for Cancer Research | Phase 1/2 | CCC |
Polyiclc Ludwig Institute for Cancer Research | Phase 1/2 | CCC |
View all 18 →
Same molecule, other indications
Ifosfamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →